CASP8 and melanoma: Treatment of SK-MEL-2 melanoma cells with TPL at various doses for 24 h caused activations of caspase-8, -9, and -3 (Figure 3(a)) and TPL-induced FAK cleavage during apoptosis (Figure 5(a)).